Molecular diagnostics: a healthcare perspective.
Recent progress in the development of molecular diagnostics in medicine has been rapid and the hope has been expressed by some people that it will soon be possible to have a detailed 'genetic readout' to assist in the diagnosis of treatment of a variety of diseases. However, such an outcome may be neither achievable nor desirable when viewed from the perspective of suppliers of healthcare.
Hall
Andrew G
AG
Leukaemia Research Fund Laboratory, Northern Institute for Cancer Research, Medical School, Framlington Place, Newcastle Upon Tyne, NE2 4HH, UK. a.g.hall@ncl.ac.uk
Coulthard
Sally A
SA
Irving
Julie A E
JA
D003362:Cost-Benefit Analysis / Q000191:economics / Q000639:trends; D003695:Delivery of Health Care / Q000191:economics; D004992:Ethics, Medical; D019317:Evidence-Based Medicine; D006801:Humans; D025202:Molecular Diagnostic Techniques; D006113:United Kingdom